Skip to content

RANDOMISED CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF PLATELET-RICH PLASMA (PRP) INFILTRATION COMBINED WITH PHYSICAL EXERCISE IN CHRONIC OMALGIA

Status
Not yet recruiting
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-522700-24-00
Acronym
SHIELD-PRP
Enrollment
86
Registered
2025-10-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CHRONIC OMALGIA

Brief summary

The difference in functional improvement between the intervention group (PRP infiltration combined with physical exercise) and the control group (corticosteroid infiltration combined with physical exercise), measured by the absolute change in the Constant-Murley scale (CMS) score at 6 months post-treatment, compared to the baseline score (14). An increase ≥ 10 points in the CMS score (15), in the absence of serious treatment-related complications, is considered a therapeutic success.

Interventions

DRUGRopivacaína Altan 7
DRUG5 mg/ml solución inyectable EFG

Sponsors

Asociacion Instituto De Investigacion Sanitaria Biobizkaia
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
The difference in functional improvement between the intervention group (PRP infiltration combined with physical exercise) and the control group (corticosteroid infiltration combined with physical exercise), measured by the absolute change in the Constant-Murley scale (CMS) score at 6 months post-treatment, compared to the baseline score (14). An increase ≥ 10 points in the CMS score (15), in the absence of serious treatment-related complications, is considered a therapeutic success.

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026